Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Lugli

Showing results (161-170 of 184) with videos related to

Pageof 19
Sort By:
The Journal of Pathology|July 5, 2023
Pseudobudding: ruptured glands do not represent true tumor budsTariq Sami Haddad, Luuk van den Dobbelsteen, Sonay K Öztürk, et al.
Plos One|June 5, 2013
High myeloperoxidase positive cell infiltration in colorectal cancer is an independent favorable prognostic factorRaoul A Droeser, Christian Hirt, Serenella Eppenberger-Castori, et al.
Neoplasia (New York, N.Y.)|February 25, 2014
HLA class II antigen expression in colorectal carcinoma tumors as a favorable prognostic markerGiuseppe Sconocchia, Serenella Eppenberger-Castori, Inti Zlobec, et al.
Clinical Epigenetics|September 28, 2018
CDX2 in colorectal cancer is an independent prognostic factor and regulated by promoter methylation and histone deacetylation in tumors of the serrated pathwayJanina Graule, Kristin Uth, Elia Fischer, et al.
Disease Markers|January 23, 2015
High frequency of CD8 positive lymphocyte infiltration correlates with lack of lymph node involvement in early rectal cancerSilvio Däster, Serenella Eppenberger-Castori, Christian Hirt, et al.
Journal of Clinical Pathology|May 3, 2015
Blood and lymphatic vessel invasion in pT1 colorectal cancer: an international concordance studyMotohiro Kojima, Giacomo Puppa, Richard Kirsch, et al.
Scientific Reports|May 15, 2025
Tumor budding and poorly differentiated clusters as a biological continuum in colorectal cancer invasion and prognosisTariq Sami Haddad, John-Melle Bokhorst, Luuk van den Dobbelsteen, et al.
European Journal of Cancer (Oxford, England : 1990)|March 13, 2013
Clinical impact of programmed cell death ligand 1 expression in colorectal cancerRaoul A Droeser, Christian Hirt, Carsten T Viehl, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 27, 2017
Recommendations for reporting tumor budding in colorectal cancer based on the International Tumor Budding Consensus Conference (ITBCC) 2016Alessandro Lugli, Richard Kirsch, Yoichi Ajioka, et al.
Nature Genetics|August 10, 2004
Nonsense-mediated decay microarray analysis identifies mutations of EPHB2 in human prostate cancerPia Huusko, Damaris Ponciano-Jackson, Maija Wolf, et al.
Pageof 19

Showing results (161-170 of 184) with videos related to

Sort By:
Pageof 19
The Journal of Pathology|July 5, 2023
Pseudobudding: ruptured glands do not represent true tumor budsTariq Sami Haddad, Luuk van den Dobbelsteen, Sonay K Öztürk, et al.
Plos One|June 5, 2013
High myeloperoxidase positive cell infiltration in colorectal cancer is an independent favorable prognostic factorRaoul A Droeser, Christian Hirt, Serenella Eppenberger-Castori, et al.
Neoplasia (New York, N.Y.)|February 25, 2014
HLA class II antigen expression in colorectal carcinoma tumors as a favorable prognostic markerGiuseppe Sconocchia, Serenella Eppenberger-Castori, Inti Zlobec, et al.
Clinical Epigenetics|September 28, 2018
CDX2 in colorectal cancer is an independent prognostic factor and regulated by promoter methylation and histone deacetylation in tumors of the serrated pathwayJanina Graule, Kristin Uth, Elia Fischer, et al.
Disease Markers|January 23, 2015
High frequency of CD8 positive lymphocyte infiltration correlates with lack of lymph node involvement in early rectal cancerSilvio Däster, Serenella Eppenberger-Castori, Christian Hirt, et al.
Journal of Clinical Pathology|May 3, 2015
Blood and lymphatic vessel invasion in pT1 colorectal cancer: an international concordance studyMotohiro Kojima, Giacomo Puppa, Richard Kirsch, et al.
Scientific Reports|May 15, 2025
Tumor budding and poorly differentiated clusters as a biological continuum in colorectal cancer invasion and prognosisTariq Sami Haddad, John-Melle Bokhorst, Luuk van den Dobbelsteen, et al.
European Journal of Cancer (Oxford, England : 1990)|March 13, 2013
Clinical impact of programmed cell death ligand 1 expression in colorectal cancerRaoul A Droeser, Christian Hirt, Carsten T Viehl, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 27, 2017
Recommendations for reporting tumor budding in colorectal cancer based on the International Tumor Budding Consensus Conference (ITBCC) 2016Alessandro Lugli, Richard Kirsch, Yoichi Ajioka, et al.
Nature Genetics|August 10, 2004
Nonsense-mediated decay microarray analysis identifies mutations of EPHB2 in human prostate cancerPia Huusko, Damaris Ponciano-Jackson, Maija Wolf, et al.
Pageof 19